GleamWall
中文EN

POSC POSITRON CORP

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 844985 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin-572.6%
Operating margin-2,287.6%
Net margin-2,307.6%
FCF margin—
EBITDA margin-2,278.9%

Returns

ROE-2,479.9%
ROA—
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets115.0%
Debt / equity—
Current ratio0.71x
Interest coverage-75.37x

Cash quality & payout

Operating cash flow / net income0.37x
Accruals ratio—
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$461,452$587,500
Cost of revenue$2.58M$929,484
Gross profit-$2.11M-$341,984
SG&A expense$8.38M$1.86M
Operating income-$10.50M-$2.21M
Interest expense$125,338$142,402
Net income-$10.60M-$2.38M
EBITDA-$10.47M-$2.18M
EPS (basic)-0.34-0.09
EPS (diluted)-0.34-0.09
Weighted avg. shares (diluted)30.89M25.98M
Banking
Deposits$375,000$375,000
Balance sheet
Cash & equivalents$2.52M$69,791
Receivables$8,333$16,667
Inventory$680,000$1.26M
Current assets$3.34M$1.35M
PP&E, net$105,752$34,103
Total assets$4.00M$1.80M
Current liabilities$2.40M$2.43M
Long-term debt$153,686$24,302
Total debt$153,686$24,302
Total liabilities$2.56M$2.46M
Shareholders' equity$1.44M-$656,725
Net debt-$2.37M-$45,489
Shares outstanding32.80M27.31M
Cash flow statement
Operating cash flow-$4.70M-$1.73M
Investing cash flow-$99,026—
Financing cash flow$7.25M$1.70M
Depreciation & amortization$27,377$22,055
Stock-based compensation$4.98M—

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.